• Super-Enhancer LINC01977 Drives Early LUAD via TGF-β/SMAD3 A

  2026-06-13

  Zhang et al. reveal that super-enhancer-driven LINC01977 promotes early-stage lung adenocarcinoma malignancy by hijacking the canonical TGF-β/SMAD3 signaling pathway. Their work identifies a novel lncRNA-driven feedback mechanism with direct implications for therapeutic targeting and disease progression monitoring.

• SB202190: Selective p38 MAP Kinase Inhibitor for Inflammatio

  2026-06-12

  SB202190 (FHPI) is a highly selective p38α/β MAP kinase inhibitor widely used in inflammation and cancer therapeutics research. Its ATP-competitive inhibition profile, robust cellular activity, and proven utility in disease models make it a cornerstone for dissecting MAPK-related signaling pathways.

• Pharmacokinetic Variability of Corydalis saxicola Alkaloids

  2026-06-12

  This study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of key alkaloids from Corydalis saxicola Bunting. Through integrated in vivo and in vitro models, it demonstrates that disease status and transporter/enzyme expression critically shape systemic and hepatic exposures, highlighting the importance of context-specific drug dosing in MASH research.

• Latrunculin B Inhibitor: Precision in Actin Cytoskeleton Dis

  2026-06-11

  Latrunculin B empowers researchers to dissect actin-dependent processes with rapid, transient, and highly specific inhibition, streamlining cytoskeletal organization studies and advanced cellular actin dynamics research. Leverage APExBIO’s Latrunculin B for reproducible, short-term actin filament disruption and gain robust, interpretable data in complex cell-based assays.

• 2-APB and Calcium Signaling: Strategic Insights for Translat

  2026-06-11

  This thought-leadership article delivers mechanistic clarity and strategic guidance for translational researchers leveraging 2-APB (2-aminoethoxydiphenyl borate) in dissecting intracellular calcium dynamics. Integrating new evidence from cardiovascular and cell fate studies, it positions 2-APB as a pivotal tool for modeling disease-relevant calcium signaling and highlights its competitive edge, translational value, and future directions. The piece contextualizes APExBIO’s offering within the fast-evolving landscape and links to key resources for protocol optimization.

• Antiarrhythmic Drugs and KCa2 Channel Modulation in AF Resea

  2026-06-10

  This article examines a pivotal study assessing the effects of various antiarrhythmic agents, including Dronedarone (Multaq), on small conductance calcium-activated potassium (KCa2.X) channels in the context of atrial fibrillation (AF). The findings clarify the mechanistic selectivity of widely used drugs, highlighting critical implications for targeted atrial fibrillation treatment and cardiac arrhythmia pharmacology.

• HyperScribe™ T7 Cy5 RNA Labeling Kit in Advanced mRNA Probe

  2026-06-10

  Explore how the HyperScribe T7 High Yield Cy5 RNA Labeling Kit enables high-precision, customizable fluorescent RNA probe synthesis for next-generation mRNA applications. This article uniquely connects advanced Cy5 labeling technology to evolving assay demands and the latest breakthroughs in targeted RNA delivery.

• Super-Enhancer Hijacking of LINC01977 Fuels Early LUAD Progr

  2026-06-09

  Zhang et al. uncovered how super-enhancer hijacking drives LINC01977 overexpression, fueling malignancy in early-stage lung adenocarcinoma by activating the canonical TGF-β/SMAD3 pathway. These findings clarify an epigenetic mechanism underlying tumor progression and offer a potential therapeutic target for intervention.

• Leveraging Dextromethorphan Hydrobromide for Translational N

  2026-06-09

  This article examines the mechanistic foundation and translational potential of Dextromethorphan hydrobromide as a research-grade NMDA receptor antagonist. Integrating insights from metabolic disease research and recent advances in neuroprotection, we offer strategic guidance for researchers navigating the intersection of excitotoxicity inhibition, cerebral ischemia modeling, and cross-domain therapeutic innovation.

• Tetraethylammonium Chloride: Precision in K+ Channel Blockad

  2026-06-08

  Tetraethylammonium chloride (TEAC) stands out for its dual-site K+ channel inhibition, enabling nuanced interrogation of ion conduction in vascular and metabolic research. This article details robust experimental workflows, troubleshooting tactics, and translational insights, with a practical bridge from reference studies to optimized laboratory protocols.

• Practical Guide to 740 Y-P: PI 3-Kinase Activator in Cell Re

  2026-06-08

  740 Y-P is a potent, cell-permeable PI 3-kinase activator designed for precise modulation of the PI3K/AKT pathway in cell-based and biochemical assays. It is best suited for vesicular trafficking research, neuronal cell survival experiments, and cancer signaling studies where direct control of PI3K activation is required. Use is not recommended in workflows that require ethanol solubility or extended solution storage.

• Lamotrigine in Translational Research: New Mechanistic Horiz

  2026-06-07

  This thought-leadership article delivers an advanced, evidence-driven perspective on Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine), highlighting its dual sodium channel blocking and serotonin pathway inhibition. Bridging mechanistic insight with practical protocols, it interprets emerging blood-brain barrier (BBB) models and provides actionable guidance for translational researchers targeting neurological and cardiac disorders. Drawing on recent literature and competitive analyses, it positions APExBIO’s high-purity Lamotrigine as a cornerstone for reproducible, future-facing CNS and cardiac research.

• Radioiodinated Balsalazide for Selective Imaging of Ulcerati

  2026-06-06

  This study introduces a highly selective radiotracer, [125/131I]balsalazide, for imaging ulcerative colitis (UC) in mouse models. The research establishes a robust radioiodination protocol and demonstrates the tracer's high in vivo colon specificity, addressing prior limitations in radiotracer stability and biodistribution monitoring over 24 hours.

• Immobilized Microalgae Extracts Enhance Antioxidant Packagin

  2026-06-05

  This study demonstrates that immobilizing Chlorella sp. in a silk fibroin–reinforced sodium alginate matrix nearly doubles antioxidant yield and biomass compared to suspension cultures. The resulting extracts, when incorporated into biodegradable films, significantly improve oxidative stability and food preservation, offering a sustainable approach to active packaging.

• YM 58483 (BTP2): Applied SOCE Inhibition in Fibrosis Models

  2026-06-05

  YM 58483 (BTP2) delivers highly selective SOCE inhibition, empowering immunology and fibrosis researchers to dissect calcium-dependent pathways with precision. Its proven effectiveness in modulating the ORAI2/JNK/NFAT1/TGF-β1 axis makes it a pivotal tool for modeling postirradiation tissue fibrosis and T cell-driven responses.

11467 records 1/765 page Next 12345 下5页 Last page